Home/Filings/4/0001179110-17-002196
4//SEC Filing

DEPOMED INC 4

Accession 0001179110-17-002196

CIK 0001005201operating

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 7:34 PM ET

Size

7.5 KB

Accession

0001179110-17-002196

Insider Transaction Report

Form 4
Period: 2017-02-08
Gosling Matthew M
VP, General Counsel
Transactions
  • Award

    Restricted Stock Units

    2017-02-08+37,00037,000 total
    Common Stock (37,000 underlying)
  • Award

    Stock Options

    2017-02-08+87,00087,000 total
    Exercise: $17.09Exp: 2027-02-08Common Stock (87,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
  • [F2]These restricted stock units are scheduled to vest 25% on December 1, 2017, 25% on December 1, 2018, 25% on December 1, 2019, and 25% on December 1, 2020, assuming continued employment through the applicable vesting date.
  • [F3]These stock options are exercisable in 48 equal monthly installments.

Issuer

DEPOMED INC

CIK 0001005201

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001005201

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 7:34 PM ET
Size
7.5 KB